|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
CAOONL|ncf11875886
(VIAF cluster)
|
|
003
|
|
|
CAOONL |
|
005
|
|
|
20200415000000.0 |
|
008
|
|
|
140411n|fazvnnaabn || aaa d |
|
035
|
|
|
‡a
(CAOONL)ncf11875886
|
|
035
|
|
|
‡a
(CaOONL)ncf11875886
|
|
035
|
|
|
‡a
(CaQQLA)n 2014183443
|
|
040
|
|
|
‡a
CaQQLA
‡b
fre
‡e
rda
‡c
CaQQLA
|
|
100
|
1 |
|
‡a
Thomas, Josse R.
|
|
670
|
|
|
‡a
Global new drug development, 2014:
‡b
ECIP t.p. (Josse R. Thomas)
|
|
919
|
|
|
‡a
globalnewdrugdevelopment
‡A
Global new drug development, 2014:
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2014
‡9
1
|
|
996
|
|
|
‡2
J9U|987007348247605171
|
|
996
|
|
|
‡2
WKP|Q120482405
|
|
996
|
|
|
‡2
ISNI|0000000078400339
|
|
996
|
|
|
‡2
LC|n 85194779
|
|
996
|
|
|
‡2
LC|n 79043831
|
|
996
|
|
|
‡2
BIBSYS|15034832
|
|
996
|
|
|
‡2
WKP|Q67223414
|
|
996
|
|
|
‡2
NTA|371529891
|
|
996
|
|
|
‡2
WKP|Q67647144
|
|
996
|
|
|
‡2
WKP|Q89257506
|
|
996
|
|
|
‡2
ISNI|0000000021733714
|
|
996
|
|
|
‡2
WKP|Q67217584
|
|
996
|
|
|
‡2
N6I|vtls001313105
|
|
996
|
|
|
‡2
NTA|251137481
|
|
996
|
|
|
‡2
SUDOC|156601893
|
|
996
|
|
|
‡2
NTA|070126968
|
|
996
|
|
|
‡2
LC|nr 95041196
|
|
996
|
|
|
‡2
BNF|16433131
|
|
996
|
|
|
‡2
NUKAT|n 2006140131
|
|
996
|
|
|
‡2
DNB|1058624202
|
|
996
|
|
|
‡2
J9U|987007449699905171
|
|
996
|
|
|
‡2
ISNI|0000000433800936
|
|
996
|
|
|
‡2
ISNI|0000000459545128
|
|
996
|
|
|
‡2
ISNI|0000000451463443
|
|
996
|
|
|
‡2
W2Z|15034832
|
|
996
|
|
|
‡2
SUDOC|280131259
|
|
996
|
|
|
‡2
LC|n 2001080137
|
|
996
|
|
|
‡2
WKP|Q75510720
|
|
996
|
|
|
‡2
DNB|1157520634
|
|
996
|
|
|
‡2
BNCHL|10000000000000000171582
|
|
996
|
|
|
‡2
JPG|500035014
|
|
996
|
|
|
‡2
WKP|Q87622815
|
|
996
|
|
|
‡2
J9U|987007451237205171
|
|
996
|
|
|
‡2
BNF|16433133
|
|
996
|
|
|
‡2
SUDOC|234337443
|
|
996
|
|
|
‡2
SUDOC|11376345X
|
|
996
|
|
|
‡2
ISNI|0000000395259412
|
|
996
|
|
|
‡2
N6I|vtls000259027
|
|
996
|
|
|
‡2
ISNI|0000000389641412
|
|
996
|
|
|
‡2
SUDOC|204413745
|
|
996
|
|
|
‡2
ISNI|0000000050909475
|
|
996
|
|
|
‡2
SUDOC|168090414
|
|
996
|
|
|
‡2
DNB|1228152152
|
|
996
|
|
|
‡2
JPG|500060485
|
|
996
|
|
|
‡2
ISNI|0000000384335950
|
|
996
|
|
|
‡2
NII|DA02680824
|
|
996
|
|
|
‡2
ISNI|0000000032566632
|
|
996
|
|
|
‡2
SUDOC|245326308
|
|
996
|
|
|
‡2
JPG|500019597
|
|
996
|
|
|
‡2
DNB|106627813X
|
|
996
|
|
|
‡2
LC|nb2019006355
|
|
996
|
|
|
‡2
WKP|Q116768200
|
|
996
|
|
|
‡2
NUKAT|n 2018290707
|
|
996
|
|
|
‡2
NUKAT|n 2017036825
|
|
996
|
|
|
‡2
WKP|Q27660469
|
|
996
|
|
|
‡2
DNB|1031582134
|
|
996
|
|
|
‡2
LC|nb2021000742
|
|
996
|
|
|
‡2
SUDOC|155505033
|
|
996
|
|
|
‡2
LC|nb 98067509
|
|
996
|
|
|
‡2
DNB|1157863574
|
|
996
|
|
|
‡2
ISNI|0000000368733588
|
|
996
|
|
|
‡2
B2Q|0000295234
|
|
996
|
|
|
‡2
BIBSYS|90234550
|
|
996
|
|
|
‡2
BAV|495_277530
|
|
996
|
|
|
‡2
NTA|173612245
|
|
996
|
|
|
‡2
NUKAT|n 2015147834
|
|
996
|
|
|
‡2
NLA|000035729353
|
|
996
|
|
|
‡2
LC|nr 97005163
|
|
996
|
|
|
‡2
WKP|Q2334027
|
|
996
|
|
|
‡2
RERO|A003897425
|
|
996
|
|
|
‡2
LC|n 86079303
|
|
996
|
|
|
‡2
BIBSYS|90259173
|
|
996
|
|
|
‡2
ISNI|000000039046613X
|
|
996
|
|
|
‡2
LIH|LNB:B8_y_1;=B_a_
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Thomas, Josse R.
‡2
ISNI|0000000433800936
‡3
exact name
|
|
998
|
|
|
‡a
Thomas, Josse R.
‡2
LC|n 2014183443
‡3
exact title: (1.00, 'globalnewdrugdevelopment', 'globalnewdrugdevelopment')
|
|
998
|
|
|
‡a
Thomas, Josse R.
‡2
BIBSYS|14057358
‡3
exact title: (1.00, 'globalnewdrugdevelopment', 'globalnewdrugdevelopment')
|
|
998
|
|
|
‡a
Thomas, Josse R.
‡2
NUKAT|n 2018107147
‡3
exact title: (1.00, 'globalnewdrugdevelopment', 'globalnewdrugdevelopment')
|
|
998
|
|
|
‡a
Thomas, Josse R.
‡2
J9U|987007348247605171
‡3
viafid
|
